Home
Aclaris Therapeutics Inc

Aclaris Therapeutics Inc Market Share Analysis for February 2026

aclaris is a biopharmaceutical company that strives to translate scientific discoveries into everyday victories in dermatology, and beyond. learn about our pipeline.

Health > Biotechnology and Pharmaceuticals

Domainaclaristx.com

Year Founded2012

Employees51 - 200

Annual Revenue$15M - $25M

Aclaris Therapeutics Inc

Aclaris Therapeutics Inc (including company regionals)

aclaristx.com

See more website traffic and engagement information

Aclaris Therapeutics Inc Revenue up to February 2026 is 15M - 25M

revenue generated by Aclaris Therapeutics Inc top domains

Aclaris Therapeutics Inc top domains revenue over 3 years

Revenue for Aclaris Therapeutics Inc top domains

aclaristx.com15M - 25M

See more with Sales Intelligence

Total visits to Aclaris Therapeutics Inc's top domains

Understand Aclaris Therapeutics Inc market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

aclaristx.com4.3K

See more with Sales Intelligence

Avg. visit duration in Aclaris Therapeutics Inc's top domains

Analyze Aclaris Therapeutics Inc engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

aclaristx.com00:00:20

See more with Sales Intelligence

Avg. pageviews on Aclaris Therapeutics Inc's top domains

See how Aclaris Therapeutics Inc keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

aclaristx.com1.82

See more with Sales Intelligence

Aclaris Therapeutics Inc top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Aclaris Therapeutics Inc

These are the website technologies, by industry, used by Aclaris Therapeutics Inc top domains

Advertising (2)

DoubleClick

Content Management System (2)

Wix

Mobile (2)

Meta Viewport

Business Solutions (1)

DocuSign

More Technologies

7

See all

News & Signals from Aclaris Therapeutics Inc

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsAclaris Therapeutics, Inc. attends event AAD Annual Meeting 2026.Aclaris Therapeutics announces ePoster presentation on Phase 2a trial results of ATI-2138 for moderate-to-severe Atopic Dermatitis at AAD Annual Meeting 2026.

NewsAclaris Therapeutics, Inc. attended event Stifel 2025 Healthcare Conference on Nov 12th '25.* On Wednesday November 12, 2025, at 1:20 PM EST, Aclaris' President and Chief Operating Officer Dr. Hugh Davis and other members of Aclaris' senior leadership team will participate in a fireside chat during the Stifel 2025 Healthcare Conference in New York, NY.

NewsAclaris Therapeutics, Inc. attends event 2025 R&D Day.WAYNE, Pa., Sept. 30, 2025 (GLOBE NEWSWIRE) - Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today announced that the Company will host it's 2025 R&D Day in Midtown, New York on Tuesday, October 14, 2025 at 8:00 AM ET to discuss the Company's progress in addressing therapeutic gaps in immuno-inflammatory markets.